Michelle Lisowski is a Principal Scientist at Pfizer, where they have led formulation development for biotherapeutic monoclonal antibodies and fusion proteins since 2009. Previously, Michelle worked as a Research Scientist II at Wyeth Biotech from 1999 to 2010, focusing on the formulation development of humanized recombinant monoclonal antibodies. They began their career at DuPont Pharmaceuticals from 1987 to 1999, supervising a Cell Culture lab and authoring GMP documents. Michelle holds a Bachelor of Science degree in Biology from Rivier University, earned in 1986.
This person is not in the org chart
This person is not in any teams
This person is not in any offices